Side-by-side comparison of AI visibility scores, market position, and capabilities
Wisp is a telehealth platform for women's sexual and reproductive health providing online consultations and medication delivery for birth control, UTIs, and sexual wellness.
Wisp is a women's health telehealth company founded in 2018 that provides convenient online care for sexual and reproductive health conditions including birth control, UTIs, STI treatment, yeast infections, bacterial vaginosis, and sexual wellness. The platform allows patients to consult with licensed providers online and receive prescription medications delivered by mail within 24 to 48 hours without requiring an in-person visit. Wisp operates in all 50 US states and has served over a million patients through its digital-first model. The company raised $25M and targets working women who want convenient access to reproductive health care without taking time off for in-person appointments. Wisp differentiates from general telehealth platforms by specializing exclusively in women's sexual and reproductive health, with clinical protocols and provider training optimized for the conditions most frequently experienced by women. The company offers both one-time treatment consultations and subscription plans for ongoing contraception management. Wisp has built a strong consumer brand through social media and content marketing focused on normalizing conversations about women's sexual health.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.